Table of Contents

Pathogenesis

• You have access

  Induction of Pauci-Immune Necrotizing and Crescen-Tic Glomerulonephritis (NCGN) by Intravenous Administration of Anti-Myeloperoxidase (Anti-MPO) Antibodies to Recombinase Activating Gene-2 Deficient (Rag-2 -/-) Mice

  JC Jennette, H Xiao, P Heeringa, Z Liu, P Hu, M Zhao, Y Aratani and RJ Falk

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13;
• You have access

  Induction of Necrotizing and Crescentic Glomeru-Lonephritis (NCGN) and Small-Vessel Vasculitis (SVV) by Adoptive Transfer of Anti-Myeloperoxidase (Anti-MPO) Lymphocytes into Recombinase Activating Gene-2 Deficient (Rag-2 -/-) Mice

  H Xiao, P Heeringa, Z Liu, P Hu, M Zhao, Y Aratani, RJ Falk and JC Jennette

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13;
• You have access

  Contribution of Activated Neutrophils and Mpo-Anca to the Development of Crescentic Glomeru-Lonephritis in Scg/Kj Mice

  A Ishida-Okawara, T Ito-Ihara, T Ono, E Muso, K Saiga, K Nemoto and K Suzuki

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13-SII-14;
• You have access

  Known infectious causes of vasculitis in man

  Stanley J. Naides, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-15-SII-19;
• You have access

  HCV and cryoglobulinemic vasculitis

  C. Ferri, MD, A.L. Zignego, MD, D. Giuggioli, MD, M. Sebastiani, MD, M. Cazzato, MD, A. Antonelli, MD, L. La Civita, MD, P. Fadda, MD, G. Longombardo, BS and S. Pileri, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-20-SII-23;
• You have access

  Infections in primary vasculitides

  J.W. Cohen Tervaert, MD, PhD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-24-SII-26;
• You have access

  Staphylococcal Toxic-Shock-Syndrome-Toxin-1 (TSSt-1) is a Risk Factor for Disease Relapse in Wegener’s Granulomatosis

  ER Popa, B van der Meer, J Arends, WM Manson, NA Bos, CGM Kallenberg, JW Cohen Tervaert and CA Stegeman

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-27;
• You have access

  Chlamydia Pneumoniae and Giant-Cell Arteritis: Failure to Detect Chlamydia Pneumoniae in Temporal Artery Biopsies by Polymerase Chain Reaction in 90 Cases and 90 Controls

  MJ Regan, BJ Wood, Y-H Hsieh, ML Theodore, TC Quinn, DB Hellmann, WR Green, CA Gaydos and JH Stone

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-27;
• You have access

  Pathogenic mechanisms in giant cell arteritis

  Cornelia M. Weyand, MD and Jörg J. Goronzy, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-28-SII-32;
• You have access

  Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis

  J. Charles Jennette, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-33-SII-38;
• You have access

  Superantigenic Activation of T Lymphocytes and Endothelial Cells: A Mechanism for Superantigen-Induced Vasculitis

  PA Brogan, V Shah, N Klein and MJ Dillon

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-39;
• You have access

  Analysis of Autoantibody Repertoires in Small and Medium Sized Vessel Vasculitis: Evidence for Disease-Specific Perturbations in Classic Polyarteritis Nodosa (PAN), Micropolyangiitis (MPA), Churg-Strauss Syndrome (CSS) and Wegener’s Granulomatosis (WG)

  Y Chanseaud, L Guillevin, M Kambouchner, MC Boissier and L Mouthon

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-39;
• You have access

  Granuloma formation, implications for the pathogenesis of vasculitis

  Michael C. Sneller, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-40-SII-43;
• You have access

  Chemokine Receptor Expression on CD4+ and CD8+ Memory T-Cells and in Granulomas in Wegener’s Granulomatosis

  P Lamprecht, A Erdmann, A Mueller, E Csernok, H Bruehl, WL Gross and M Mack

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;
• You have access

  Genetic Resistance to Wegener’s Granulomatosis—A Role for CCR5 in Patients Without Antineutrophil Cytoplasmic Antibodies

  Y Zhou, D Huang, C Farver and G Hoffman

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;
• You have access

  Endothelial cell biology, perivascular inflammation, and vasculitis

  Maria C. Cid, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-45-SII-49;
• You have access

  Novel Effects of Inflammatory Cell Proteases on Vascular Endothelia

  GA Preston, WF Pendergraft, JJ Yang, JC Jennette and RJ Falk

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-50;
• You have access

  Understanding the pathogenesis of ANCA: Where are we today?

  Gloria A. Preston, PhD, Jia Jin Yang, MD, Hong Xiao, MD and Ronald J. Falk, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-51-SII-54;
• You have access

  TNF-α-Accelerated Apoptosis Abrogates Anca-Mediated Neutrophil Respiratory Burst by a Caspase-Dependent Mechanism

  R Kettritz, J Scheumann, Y Xu, FC Luft and H Haller

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-55;
• You have access

  Membrane Expression of Neutrophil Proteinase 3 (Pr3) Is Associated With Relapse in Pr3-Anca Related Vasculitis

  AA Rarok, CA Stegeman, PC Limburg and CGM Kallenberg

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-55;
• You have access

  ANCA subsets: Influence on disease phenotype

  Ulrich Specks, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-56-SII-59;
• You have access

  Sequential Epitope Mapping of the Myeloperoxidase Antigen

  DM Wynn and JA James

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-60;
• You have access

  Genetics of ANCA-associated vasculitides

  Cees G.M. Kallenberg, MD, PhD, Agnieszka Rarok, BSc and Coen A. Stegeman, MD, PhD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-61-SII-63;
• You have access

  Membrane Expression of Proteinase 3 is Genetically Controlled

  A Schreiber, A Busjahn, FC Luft and R Kettritz

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-64;
• You have access

  Genetic Polymorphisms in TNF, IL-1, IL-6 And Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Wegener’s Granulomatosis (WG)

  Y Zhou, D Huang and GS Hoffman

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-64;
• You have access

  Classification of anti–endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications

  Yehuda Shoenfeld, MD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-65-SII-66;
• You have access

  HMG-CoA Reductase Inhibitors Decrease Anca-Mediated Activation Of Human Neutrophils

  M Choi, S Rolle, M Rane, H Haller, FC Luft and R Kettritz

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-68;
• You have access

  Host and viral genes that control herpesvirus vasculitis

  Herbert W. Virgin, MD, PhD

  Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-7-SII-12;